LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 16,351 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 16,351 | -5.8% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 17,351 | -16.0% | 0.00% | -100.0% |
| Q4 2022 | $843 | -99.9% | 20,659 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $843,000 | -30.2% | 20,659 | -6.0% | 0.00% | -33.3% |
| Q2 2022 | $1,208,000 | +1.2% | 21,968 | -33.2% | 0.01% | +50.0% |
| Q1 2022 | $1,194,000 | -0.8% | 32,865 | +27.2% | 0.00% | 0.0% |
| Q4 2021 | $1,204,000 | +18.3% | 25,830 | +28.3% | 0.00% | 0.0% |
| Q3 2021 | $1,018,000 | -54.5% | 20,128 | -63.1% | 0.00% | 0.0% |
| Q2 2021 | $2,238,000 | +41.5% | 54,508 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $1,582,000 | -76.6% | 54,508 | +24.6% | 0.00% | 0.0% |
| Q4 2020 | $6,774,000 | +63.3% | 43,738 | -67.4% | 0.00% | -75.0% |
| Q3 2020 | $4,148,000 | – | 134,332 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $54,715,742 | 20.16% |
| HHLR ADVISORS, LTD. | 6,436,533 | $432,341,922 | 9.65% |
| Paradigm Biocapital Advisors LP | 2,025,480 | $136,051,492 | 9.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,828 | $75,487,527 | 9.13% |
| RA Capital Management | 6,264,707 | $420,800,369 | 8.28% |
| Iron Triangle Partners LP | 452,629 | $30,403,090 | 4.44% |
| Nicholas Investment Partners, LP | 593,010 | $39,832,482 | 2.98% |
| Old Well Partners, LLC | 45,200 | $3,036,084 | 2.63% |
| Avidity Partners Management LP | 967,000 | $64,953,390 | 2.62% |
| E Fund Management (Hong Kong) Co., Ltd. | 52,759 | $3,544 | 2.23% |